HIV+Hep in the News

In 2022, copay cards covered $19 billion worth of out-of-pocket costs for patients, according to Carl Schmid, executive director at the HIV + Hepatitis Policy Institute. “Imagine if we didn’t have that? The American people would have to come up with 19 more billion dollars,” Schmid told McClatchy News.

“This ruling is a big win for people living with HIV and [people taking] other prescription drugs who have a hard enough time already affording their meds,” TheBody was told on a call by Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. He also said in a press release: “We are thrilled that the Court has taken the side of patients who have been struggling to afford their prescription drugs due to the greedy actions of insurers and their pharmacy benefits managers. We call on the Biden administration and states to immediately enforce this decision and not take any further steps to undermine the copay assistance that allows patients to access their essential medications.”